PGR and neoplasm: However, in the same patient group, 42.7 % of PgR+ primary tumour patients had PgR− metastases, whilst 16.0 % of PgR− primary tumour patients had PgR+ metastases, indicating a greater loss than gain of PgR expression in metastatic tissue.